Alaunos Therapeutics TCRT
NASDAQ TCRT
$0.87 -0.10 (-9.93%)
As of: Sep 30, 2026 · 3:56 PM EDT

Alaunos Therapeutics (TCRT) Non-Current Debt (2021 - 2022)

Updated

Alaunos Therapeutics' Non-Current Debt came in at -$5.41 million for FY2018.

Analysis

Alaunos Therapeutics (TCRT) Non-Current Debt (2021 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 37.34 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 62.48 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -108.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 23.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Alaunos Therapeutics 2.39 Mn -1.41 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 4.47 Mn
Mar 31, 2022 10.32 Mn
Dec 31, 2021 16.25 Mn
Sep 30, 2021 12.17 Mn
API Access

Alaunos Therapeutics Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=TCRT&period=max&api_key=YOUR_API_KEY